Levels of soluble Fas-APO-1 in patients with Behçets diseaseReportar como inadecuado

Levels of soluble Fas-APO-1 in patients with Behçets disease - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Mediators of Inflammation - Volume 7 1998, Issue 2, Pages 111-114

Immunohistology Laboratory, Medicine University of Tunis, Pavillon VI, 9 rue Dr Z. Essafi , Tunis 1007, Tunisia

Department of Respiratory Diseases, Pav II, Ariana, Tunisia

Department of Rheumatology, Marsa Hospital, Tunisia

Copyright © 1998 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The aim of this study was to quantify soluble Fas-APO1 sFas-APO-1 protein in the serum of patients with Behcet-s disease BD in active and inactive stages, compared with patients with systemic lupus erythematosus SLE and patients with rheumatoid arthritis RA. Soluble Fas-APO-1 was quantified using a sandwich enzyme-linked immunosorbent assay. Increased serum sFas-APO-1 levels were observed in active BD, compared with inactive BD, RA patients and SLE patients. Increased serum sFas-APO-1 levels were correlated with the presence of neurologic manifestations or pulmonary involvement in active BD. In conclusion, increased levels of sFas-APO-1 occurred frequently and exclusively in active BD patients. Preliminary evidence suggested that elevated levels of sFas-APO-1 are associated with the clinical stage and clinical manifestations in BD.

Autor: K. Hamzaoui, A. Hamzaoui, L. Zakraoui, and A. Chabbou

Fuente: https://www.hindawi.com/


Documentos relacionados